As part of the ramp of Versarien (VRS) shares in the summer of 2018 ahead of the September bailout placing, the company announced a string of exciting deals. Hmmm.  Given that revenues from graphene are still negligible maybe it is worth hapless Nomad Bobbie Hilliam of Canaccord asking a few questions. He would not want to get caught with his trousers down as he did with the Quindell fraud would he? Take the 18 June 2018 RNS “Collaboration agreement with MediaDevil."

Previously writing on marketing services group System1 (SYS1), in November I concluded its stated upside potential is still very much to be proven and the shares only on the watchlist. Today “Trading Update and Planned Share Buyback”…

The AIM Casino, a.k.a. The World's Most successful Growth Market, has released its market statistics for the period to the end of January 2020 and this saw the number of companies reduce from 863 to 851, a net reduction of 12.  If you ignore Open Orphan (ORPH) which appears as both a new entry and a cancellation there was 1 readmission and 1 new admission raising a grand total of £7 million in new money.

AIM dog Catenae Innovations (CTEA ) spent the latter part of last week contacting creditors persuading them to swap sums owed for equity in a truly shite deal for those owed cash. What it did not say is that at least one creditor was given a far better deal. Some, it seems, are more equal than others.

You can always rely on the Royal Mail (RMG), right? As a postal service I think it is a world leader but the trouble is that in today's world that is far from enough. Today's nine month trading update may have started with an assertion that 'we had a busy Christmas season...overall, our recent trading performance has been broadly in line with our expectations', but dig a little deeper and issues emerge. After all, there is a reason why the shares are at an all-time low today, at not even a third of the 600p level achieved in early 2018…

Early this year we showed the top shorted London-listed shares at the start of 2020. How's the performance after the first month of the year? (those in bold remain from 2019)...

Hello, Share Breakers. It’s rare that I return to the same share shortly after a commendation. But for this company, I’m coming back a third time in fairly short order...

Software and services provider to the publishing and media industry, Ingenta (ING) has updated on its year ended 31^st December 2019 and emphasised “a leaner, more responsive business better equipped to service its diverse customer base”…

Plant Health Care (PHC) has today followed two January announcements with another – which has currently helped the shares to 12.5p, a further approaching 9% higher…

Payments technology company PCI-PAL (PCIP) has updated including that it “is pleased with the strong performance against key metrics in the first half of the year (to 31st December 2019), in particular the growth in revenue… is confident that we will continue the momentum built in the first half against key metrics and that the company's strategy and market positioning means it is well placed to continue the progress made in the last 12 months”. The shares have currently responded higher to 43.5p – though still comparing to more than 78p reached in early 2018…

In today's podcast, interrupted by the pest Lucian, I look at Chris Akers and what he knows about Dev Clever (DEV), at Versarien (VRS) and an RNS from February 2017 which I urge its hapless Nomad Bobbie Hilliam at Canaccord to consider carefully as his client runs out of money again, at Andalas (ADL), Eurasia (EUA) and Tesla (TSLA). I consider the woes of Bidstack (BIDS) and a company with even less money, the curious trading statement from Zoetic (ZOE) and then do the maths, again, on UK Oil & Gas (UKOG).

Concepta (CPT) has updated emphasising “following the appointment of Penny McCormick as Chief Executive Officer and Maddy Kennedy as Chief Financial Officer in the final quarter of last year, the company has made substantial progress to establish an effective operational structure to ensure the commercial success of myLotus®, and to advance new product opportunities”. What is this progress then?...

Previously writing on Accesso Technology (ACSO), last month I stated “the premier technology solutions provider”… trying to fool you or fooling itself? – concluding hopefully my prior warnings - most recently formal sale process “ongoing”… but no queue to pay-up! - have been heeded and currently still avoid / sell. Now “Board Change”…

Bus group Rotala (ROL) has updated including it “is pleased to announce that trading during FY 19 was in-line with market expectations”, that it “is well placed to capitalise on its enhanced position in a period when the bus industry continues to undergo considerable change” and that it “expects to maintain its progressive dividend policy”…

I may have loved up the upcoming change of CEO at Imperial Brands (IMB) on Monday, but he is coming into a vaping hornets' nest as today's update from the company observes that 'following the US FDA's ban on certain flavours of cartridge-based vapour devices and weaker than expected consumer demand for vapour, we now expect constant currency full year Group net revenue to be at a similar level to last year and adjusted earnings per share to be slightly lower than last year'…

On January 6 Bahamas Petroleum (BPC) announced that it was raising £2 million at 2p from a Bahamas based fund. On January 30^th it issued a ramptastic roadmap to drilling RNS and the shares rocketed. What more did oily spiv Jerry Keen and his colleagues at broker Shore Cap need to whir into action.

Hello, Share Shapers. A lot of my gelt is tied into Diageo (DGE). Perhaps a bit more than my usual cut-off point of no more than ten percent of my portfolio. The reason for this out-of-ordinary support is that Diageo seems one of those companies that can command zippy shares prices in times, which in world economy terms, are good or bad. But let’s have a look at the fundamentals rather than making general pronouncements...

One can only have sympathy for John Chapman, the chairman of AIM-China Filthy Forty play Origo (OPP), who came in after the damage had been done by previous management and leaving a hospital pass for whoever followed. The full horror of what Mr Chapman inherited is detailed here in the FY18 Annual Report and this morning the bad news was that Origo’s investment (and I use the term in its loosest sense) had suffered another setback as a purported bidder (unidentified!) had apparently walked in the face of a demand for arbitration being served. Given that this was about the only asset of measurable (but questionable) value, Origo shares have slumped...

Shares in ‘regenerative medical devices’ group Tissue Regenix (TRX) are currently approaching 20% higher on the day, at around 1.20p, on the back of an update including “it is anticipated that delayed orders will be dispatched over the coming weeks… All processing in the company's United States facility has also resumed with immediate effect”…

One clown is Justin Waite from Vox Markets the other is Mr Tumble who entertains folks Joshua's age on CBeebies. I explain the two big differences betweeen the two Justin the Clowns. I look at a classic feck up by London's worst Nomad Roland "Fatty" Cornish. poor man, he has a lot on his plate right now. I look at Andalas Energy (ADL) what the broker coverage of Petards (PEG) shows about the cesspit in the City and I cover just wholly unacceptable executive greed at Coro Energy (CORO). I forgot to mention crony capitalist greed at Toople (TOOP), a coke and hookers event for City spivs but you can read about it HERE. I do, however, comment on NMC Health (NMC) and Finablr (FIN).